CFC Denies Fraud Counterclaims for Lack of Scienter
Client Alert | 1 min read | 05.08.13
In response to a contractor's CDA claim for the cancellation of two purchase orders for printed circuit cards when the contractor manufactured the parts itself rather than providing the parts from specified approved sources, the government in Ulysses, Inc. v. U.S. (Apr. 30, 2013), brought counterclaims for fraud under the False Claims Act, the fraud provision of the Contract Disputes Act, and the Forfeiture of Fraudulent Claims Act. The CFC denied them all, holding that the contractor did not act in reckless disregard of the truth or falsity of its claims because neither the RFQ nor the contractor's quotation leading to the purchase order specified a particular source and, therefore, its erroneous interpretation of the purchase orders "was not so implausible as to be frivolous" and because it had advised the government that it believed it was an approved source, "making this a classic case for application of the Government knowledge defense."
Contacts
Insights
Client Alert | 4 min read | 11.19.26
Since the choppy rollout of the U.S. Small Business Administration’s (SBA) Paycheck Protection Program (PPP) in the early days of the pandemic, the long wake of enforcement actions has followed in waves. First to fall were the bad actors, relying on falsified paperwork for employees and entities and using the loan proceeds to purchase Lamborghinis. Next were those loan recipients who fell victim to the complexities and changes in the loan eligibility requirements, many of which are grounded in the SBA’s existing complex regulations regarding affiliation. While government contractor PPP loan recipients have largely stayed out of the spotlight in reported settlements and False Claims Act (FCA) litigation to date, a recent enforcement action previews that a new wave is coming with government contractors as the target.
Client Alert | 1 min read | 11.19.26
GSA and DHS Launch E-Verify Enforcement Initiative Targeting Contractors
Client Alert | 3 min read | 11.17.26
CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs
Client Alert | 9 min read | 11.17.26
Priorities and Prospects for AI Legislation in the New Congress

